Beijing Bio-targeting Therapeutics Technology Co., Ltd

This study planned to test a new treatment that uses a modified virus to attack cancer cells, combined with standard pre-surgery therapy, in people with locally advanced breast cancer. The goal was to check safety and find the best dose. However, the study was withdrawn before an…